ZEVRA THERAPEUTICS INC (ZVRA) Forecast, Price Target & Analyst Ratings

NASDAQ:ZVRA • US4884452065

Current stock price

9.83 USD
-0.07 (-0.71%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZEVRA THERAPEUTICS INC (ZVRA).

Forecast Snapshot

Consensus Price Target

Price Target
$23.46
+ 138.66% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
$0.08
Revenue Estimate
32.6M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$23.46
Upside
+ 138.66%
From current price of $9.83 to mean target of $23.46, Based on 15 analyst forecasts
Low
$18.18
Median
$23.97
High
$27.30

Price Target Revisions

1 Month
0.63%
3 Months
0.63%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for ZVRA. The average price target is 23.46 USD. This implies a price increase of 138.66% is expected in the next year compared to the current price of 9.83.
The average price target has been revised upward by 0.63% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ZVRA Current Analyst RatingZVRA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

ZVRA Historical Analyst RatingsZVRA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.33%
ZVRA was analyzed by 15 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ZVRA.
In the previous month the buy percentage consensus was at a similar level.
ZVRA was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16BTIGInitiate Buy
2025-11-06Cantor FitzgeraldMaintains Overweight -> Overweight
2025-11-06Canaccord GenuityMaintains Buy -> Buy
2025-08-13JMP SecuritiesMaintains Market Outperform -> Market Outperform
2025-07-10Cantor FitzgeraldMaintains Overweight -> Overweight
2025-07-02HC Wainwright & Co.Initiate Buy
2025-05-14Cantor FitzgeraldReiterate Overweight -> Overweight
2025-03-13GuggenheimMaintains Buy -> Buy
2025-03-13Canaccord GenuityMaintains Buy -> Buy
2025-03-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-12Citizens Capital MarketsMaintains Market Outperform -> Market Outperform
2025-03-12Cantor FitzgeraldReiterate Overweight -> Overweight
2024-11-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-14Canaccord GenuityMaintains Buy -> Buy
2024-10-11Cantor FitzgeraldReiterate Overweight
2024-10-07GuggenheimInitiate Buy
2024-10-01Cantor FitzgeraldReiterate Overweight
2024-09-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-09-24Roth MKMMaintains Buy -> Buy
2024-09-24JMP SecuritiesInitiate Market Outperform
2024-09-24Maxim GroupMaintains Buy -> Buy
2024-09-20HC Wainwright & Co.Maintains Buy -> Buy
2024-09-18Canaccord GenuityMaintains Buy -> Buy
2024-08-14Cantor FitzgeraldReiterate Overweight
2024-08-05Cantor FitzgeraldReiterate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
$0.08
Revenue Estimate
32.6M
Revenue Q2Q
59.80%
EPS Q2Q
237.33%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-0.92%
EPS (1 Month)
-3.96%
EPS (3 Months)
-22.33%

Next Earnings Summary

ZVRA is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is 0.08 USD and the consensus revenue estimate is 32.60M USD.
The next earnings revenue estimate has been revised downward by 0.92% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ZVRA revenue by date.ZVRA revenue by date.
27.461M
162.53%		23.612M
-14.02%		106.47M
350.91%		146.15M
37.27%		224.22M
53.42%		313.1M
39.64%		368.65M
17.74%		414.68M
12.49%		451.08M
8.78%		432.77M
-4.06%		429.19M
-0.83%
EBITDA
YoY % growth
ZVRA ebitda by date.ZVRA ebitda by date.
-48.598M
-103.25%		-80.614M
-65.88%		-179K
99.78%		31.926M
17,935.75%		70.686M
121.41%		119.14M
68.55%		182.68M
53.33%		221.75M
21.39%		251.33M
13.34%		243.17M
-3.25%		254.49M
4.66%
EBIT
YoY % growth
ZVRA ebit by date.ZVRA ebit by date.
-49.604M
-99.61%		-87.003M
-75.40%		-4.233M
95.13%		37.023M
974.63%		108.05M
191.85%		177.62M
64.39%		223.64M
25.91%		264.2M
18.14%		300.98M
13.92%		316.59M
5.19%		317.23M
0.20%
Operating Margin
ZVRA operating margin by date.ZVRA operating margin by date.
-180.63%-368.47%-3.98%25.33%48.19%56.73%60.66%63.71%66.72%73.15%73.91%
EPS
YoY % growth
ZVRA eps by date.ZVRA eps by date.
-1.29
-86.96%		-2.26
-75.19%		1.35
159.73%		0.50
-63.27%		1.52
205.71%		2.56
68.99%		3.28
28.21%		3.68
12.01%		4.24
15.29%		4.19
-1.15%		4.02
-4.14%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		0.08
237.33%		0.11
-91.07%		0.13
1,401.11%		0.18
-15.21%		0.30
267.26%		0.35
227.39%		0.39
197.90%		0.43
138.70%
Revenue
Q2Q % growth		32.6M
59.80%		34.882M
34.78%		37.337M
43.26%		41.327M
21.10%		48.944M
50.13%		52.945M
51.78%		56.76M
52.02%		60.252M
45.79%
EBITDA
Q2Q % growth		5.304M
242.85%		6.732M
174.56%		8.262M
5.45%		11.628M
-13.02%		N/AN/AN/AN/A
EBIT
Q2Q % growth		6.625M
223.55%		7.916M
164.21%		9.632M
132.49%		12.837M
37.81%		17.969M
171.23%		21.172M
167.46%		22.528M
133.89%		24.915M
94.09%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ZVRA Yearly Revenue VS EstimatesZVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ZVRA Yearly EPS VS EstimatesZVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -20 -40 -60 -80 -100

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.80%
EPS Next 5 Year
22.20%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
45.15%
Revenue Next 5 Year
32.28%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
54.71%
EBIT Next 5 Year
38.89%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ZEVRA THERAPEUTICS INC / ZVRA Forecast FAQ

Can you provide the average price target for ZEVRA THERAPEUTICS INC stock?

15 analysts have analysed ZVRA and the average price target is 23.46 USD. This implies a price increase of 138.66% is expected in the next year compared to the current price of 9.83.

What is the next earnings date for ZVRA stock?

ZEVRA THERAPEUTICS INC (ZVRA) will report earnings on 2026-05-11.

What are the consensus estimates for ZEVRA THERAPEUTICS INC (ZVRA) next earnings?

The consensus EPS estimate for the next earnings of ZEVRA THERAPEUTICS INC (ZVRA) is 0.08 USD and the consensus revenue estimate is 32.60M USD.

What is the expected long term growth rate for ZEVRA THERAPEUTICS INC (ZVRA)?

The expected long term growth rate for ZEVRA THERAPEUTICS INC (ZVRA) is 45.15%.